Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalMarket Capitalization

Mainz Biomed N.V (MYNZ) EBT Margin: 2022-2023

Historic EBT Margin for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -2,413.53%.

  • Mainz Biomed N.V's EBT Margin rose 182313.00% to -2,413.53% in Q4 2023 from the same period last year, while for Dec 2023 it was -2,936.50%, marking a year-over-year increase of 204340.00%. This contributed to the annual value of -2,421.80% for FY2024, which is 51470.00% up from last year.
  • As of Q4 2023, Mainz Biomed N.V's EBT Margin stood at -2,413.53%, which was up 30.40% from -3,467.71% recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed N.V's EBT Margin peaked at -2,413.53% during Q4 2023, and registered a low of -5,781.76% during Q3 2022.
  • Its 2-year average for EBT Margin is -4,056.60%, with a median of -3,852.19% in 2023.
  • Data for Mainz Biomed N.V's EBT Margin shows a peak YoY surged of 300,864bps (in 2023) over the last 5 years.
  • Over the past 2 years, Mainz Biomed N.V's EBT Margin (Quarterly) stood at -4,236.66% in 2022, then soared by 182,313bps to -2,413.53% in 2023.
  • Its last three reported values are -2,413.53% in Q4 2023, -3,467.71% for Q3 2023, and -3,314.68% during Q2 2023.